沸点	77 ºC (12 mmHg)
闪点	163 ºF
密度	0.897
折射率	1.442

危险品标志	Xn
危险类别码	R20/21/22
安全说明书	S36

来源	SDS样本
Sigma-Aldrich	浏览或下载
TCI	浏览或下载
Oakwood	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study.Noémie Boillat-Blanco et al.Journal of acquired immune deficiency syndromes (1999), 62(2), 180-189 (2012-11-29) Newer nucleosides: lamivudine and stavudine.C Katlama et al.AIDS (London, England), 10 Suppl A, S135-S143 (1996-01-01) The role of stavudine in the management of adults with HIV infection.G J Moyle et al.Antiviral therapy, 2(4), 207-218 (2001-05-01) Contribution of follicular dendritic cells to persistent HIV viremia.Jingshan Zhang et al.Journal of virology, 87(14), 7893-7901 (2013-05-10) Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integraseJones G S, et al. Antimicrobial Agents and Chemotherapy, 53(3), 1194-1203 (2009) Phasing out the use of stavudine in Singapore: how are we doing in compliance to World Health Organization (WHO) recommendations?Mar Kyaw Win et al.Annals of the Academy of Medicine, Singapore, 41(12), 615-616 (2013-01-11) The separation and detection of PET tracers via capillary electrophoresis for chemical identity and purity analysis.Shilin Cheung et al.Journal of pharmaceutical and biomedical analysis, 94, 12-18 (2014-02-19) Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.Alicen Spaulding et al.The Cochrane database of systematic reviews, (8)(8), CD008651-CD008651 (2010-08-06) Viral protein R of HIV type-1 induces retrotransposition and upregulates glutamate synthesis by the signal transducer and activator of transcription 1 signaling pathway.Akihiro Doi et al.Microbiology and immunology, 59(7), 398-409 (2015-05-21) Commentary on "Thermodynamic modeling of activity coefficient and prediction of solubility. Parts 1 and 2.".Stanley Sandler Journal of pharmaceutical sciences, 102(3), 785-785 (2013-01-22) Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.Jutarat Praparattanapan et al.Current HIV research, 10(8), 647-652 (2012-10-16) A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.Nittaya Phanuphak et al.Antiviral therapy, 17(8), 1521-1531 (2012-12-12) The artifactual nature of stavudine binding to human serum albumin. A fluorescence quenching and isothermal titration calorimetry study.Silvia Neamtu et al.Journal of pharmaceutical and biomedical analysis, 72, 134-138 (2012-11-14) Peripheral neuropathy in HIV: an analysis of evidence-based approaches.Patrice K Nicholas et al.The Journal of the Association of Nurses in AIDS Care : JANAC, 25(4), 318-329 (2014-04-05) Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Joanna Kryst et al.PloS one, 10(5), e0124279-e0124279 (2015-05-02) Non-occupational HIV post-exposure prophylaxis at a Sydney metropolitan sexual health clinic.Trine Gulholm et al.Sexual health, 10(5), 438-441 (2013-08-22) Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes.Metodi V Stankov et al.Antimicrobial agents and chemotherapy, 57(1), 543-551 (2012-11-14) Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.Yeweyenhareg Feleke et al.Ethiopian medical journal, 50(3), 221-230 (2013-02-16) Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development.Jayakrishna Ambati et al.Nature communications, 11(1), 4737-4737 (2020-09-25) Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.Stephanie Shiau et al.The Journal of pediatrics, 162(6), 1138-1145 (2013-01-15) Cardiometabolic risk factors among HIV patients on antiretroviral therapy.James N Kiage et al.Lipids in health and disease, 12, 50-50 (2013-04-12) Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.Nyan Lin Kyaw et al.The Southeast Asian journal of tropical medicine and public health, 44(2), 232-243 (2013-05-23) The pattern of attrition from an antiretroviral treatment program in Nigeria.Solomon Odafe et al.PloS one, 7(12), e51254-e51254 (2012-12-29) In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.Kyle R Hukezalie et al.PloS one, 7(11), e47505-e47505 (2012-11-21) 2?, 3?-didehydro-3?-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trialBrowne M J, et al. The Journal of Infectious Diseases, 167(1), 21-29 (1993) Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.Michele W Tang et al.The Journal of infectious diseases, 207 Suppl 2, S70-S77 (2013-05-25) Leveraging rapid implementation of an HIV treatment policy to reduce confounding in observational analysis of antiretroviral outcomes.Michael J Vinikoor et al.Tropical medicine & international health : TM & IH, 19(5), 499-500 (2014-03-22) Stavudine (d4T, Zerit).G Friedland et al.Advances in experimental medicine and biology, 394, 271-277 (1996-01-01) Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces.Dam Anh Tran et al.Sexually transmitted infections, 90(7), 538-544 (2014-03-13) Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection.A P Lea et al.Drugs, 51(5), 846-864 (1996-05-01) Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients.Pornpen Srisawasdi et al.American journal of clinical pathology, 140(4), 506-515 (2013-09-21) Severe metabolic acidosis and Fanconi syndrome during stavudine and abacavir therapy in a resource-limited setting.Rakesh D Bansie et al.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 16(6), 610-611 (2012-11-13) Caenorhabditis elegans as a model system for studying drug induced mitochondrial toxicityde Boer R, et al. PLoS ONE, 10(5), e0126220-e0126220 (2015) Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir.Alana T Brennan et al.Tropical medicine & international health : TM & IH, 19(5), 490-498 (2014-03-05) The genetic toxicity effects of lamivudine and stavudine antiretroviral agents.Nilza Nascimento Guimarães et al.Expert opinion on drug safety, 9(5), 771-781 (2010-04-10) [Follow-up of HIV-infected children receiving antiretroviral therapy in a rural area of Togo].K E Djadou et al.Medecine et sante tropicales, 22(3), 283-286 (2012-11-24) Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.Victor Musiime et al.Antiviral therapy, 19(3), 269-276 (2014-04-11) Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study.Sumit Basu et al.International journal of nanomedicine, 7, 6049-6061 (2012-12-29) From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir.Kazuhiro Haraguchi et al.Current pharmaceutical design, 19(10), 1880-1897 (2012-10-25) Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review.Alain Lafeuillade et al.AIDS reviews, 5(2), 80-86 (2003-07-25) Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy.Pere Domingo et al.PloS one, 8(2), e57347-e57347 (2013-03-08) Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.Stephen Arpadi et al.Archives of disease in childhood, 98(4), 258-264 (2012-12-12) Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine (D4T) and its comparison with other dideoxynucleosides.John C Martin et al.Antiviral research, 85(1), 34-38 (2009-10-27) [Ester derivatives of nucleoside inhibitors of reverse transcriptase: II. Molecular systems for combined therapy with 3'-azido-3'-deoxythymidine and 2',3'-didehydro-3'-deoxythymidine].Iu V Berezovskaia et al.Bioorganicheskaia khimiia, 31(5), 451-465 (2005-10-26) Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2',3'-dideoxynucleoside analogues.J P Sommadossi The Journal of infectious diseases, 171 Suppl 2, S88-S92 (1995-03-01) Stavudine: an update of its use in the treatment of HIV infection.M Hurst et al.Drugs, 58(5), 919-949 (1999-12-14) [Ester derivatives of nucleoside inhibitors of reverse transcriptase: I. Molecular transport systems for 3'-azido-3'-deoxythymidine and 2',3'-didehydro-3'-deoxythymidine].Iu V Berezovskaia et al.Bioorganicheskaia khimiia, 31(4), 339-356 (2005-08-27) Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy.N Clumeck Antiviral therapy, 3 Suppl 4, 39-43 (2000-03-21) In vitro effect of some nucleoside reverse transcriptase inhibitors against HSV-1 replication.R Nahid Samiei et al.European review for medical and pharmacological sciences, 24(3), 1454-1459 (2020-02-26) Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T).S A Riddler et al.Antiviral research, 27(3), 189-203 (1995-06-01) Stavudine once daily.Susan M Cheer et al.Drugs, 62(18), 2667-2674 (2002-12-06) Synthesis, and in vitro enzymatic and antiviral evaluation of d4T polyphosphate derivatives as chain terminators.Shiqiong Yang et al.Chemistry & biodiversity, 9(10), 2186-2194 (2012-10-20) Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS.Ma Gracia Mateo et al.Expert opinion on pharmacotherapy, 14(8), 1055-1064 (2013-03-21) Corrections for "Thermodynamic modeling of activity coefficient and prediction of solubility. Parts 1 and 2," Journal of Pharmaceutical Sciences 95(4) 2006, pp 790-809.Mahmoud Mirmehrabi et al.Journal of pharmaceutical sciences, 102(3), 786-786 (2013-01-10) Lin, T.S., et al. Biochemical Pharmacology, 17, 2713-2713 (1987) Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.M Baba et al.Biochemical and biophysical research communications, 142(1), 128-134 (1987-01-15) Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.Ankur Gupta-Wright et al.Journal of acquired immune deficiency syndromes (1999), 64(3), 261-270 (2013-07-13) Stavudine-based multiple agent combinations: initial studies and ongoing comparative trials.R L Murphy Antiviral therapy, 3 Suppl 4, 69-73 (2000-03-21) Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.Oche Agbaji et al.Journal of acquired immune deficiency syndromes (1999), 62(2), 204-207 (2012-12-01) Biologic effects and safety of stavudine: overview of phase I and II clinical trials.G Skowron The Journal of infectious diseases, 171 Suppl 2, S113-S117 (1995-03-01) High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.Steve Innes et al.BMC pediatrics, 12, 183-183 (2012-11-28) Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.Alain Makinson et al.Expert opinion on drug safety, 7(3), 283-293 (2008-05-09) Clinical pharmacokinetics of stavudine.K Z Rana et al.Clinical pharmacokinetics, 33(4), 276-284 (1997-10-29) Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.N L Siegfried et al.The Cochrane database of systematic reviews, (2)(2), CD004535-CD004535 (2006-04-21) A Claisen approach to 4'-Ed4T.William P Gallagher et al.Organic letters, 17(1), 14-17 (2014-12-19) Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometryCossarizza A, et al. Nature Protocols, 4(12), 1790-1790 (2009) Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia.Julie Bertrand et al.The Journal of infectious diseases, 209(3), 399-408 (2013-08-31) Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.Andrew Hill et al.Expert opinion on pharmacotherapy, 8(5), 679-688 (2007-03-23) Integration of High-Resolution Radiation Detector for Hybrid Microchip Electrophoresis.Jason Jones et al.Analytical chemistry, 92(4), 3483-3491 (2020-01-29)

备注